Logo
L

LAVIE CO LTD

Lavie Bio harnesses Microbiome, host and environmental OMIC interconnected BIG DATA hub that is core in its ability to Discover, Optimize and Develop products.
Country/AreaSouth Sudan
Company Emailinfo@lavie-bio.com
IndustryBusiness ServicesBusiness Services General
Company website
Company phone+972 89311900
Established2015
Company Revenue$3,695,000
Number of employees<25
SIC Code87873
NAICS Code54541
Main ProductstechnologyYalos®
http://www.linkedin.com/company/lavie-biohttps://mobile.twitter.com/laviebiohttps://www.facebook.com/laviebio123

Company News

Lavie Bio Announces Licensing Agreement for Bio-Fungicides with Corteva Agriscience
Corteva to receive exclusive rights to further develop and commercialize Lavie Bio's lead product candidates for fruit rot and powdery mildew fungicide biologicals REHOVOT, Israel, July 17, 2023 /PRNewswire/ -- Lavie Bio Ltd., a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), and...
dateJul 17, 2023
Lavie Bio Receives Canadian Regulatory Approval for Thrivus™, Expanding Global Reach
The approval by the Canadian Food Inspection Agency triples Thrivus'™ sales territory REHOVOT, Israel, May 24, 2023 /PRNewswire/ -- Lavie Bio Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), and a leading ag-biological company focusing on improving food quality,...
dateMay 24, 2023
Lavie Bio Announces Appointment of Amit Noam as its Incoming Chief Executive Officer
REHOVOT, Israel, March 29, 2023 /PRNewswire/ -- Lavie Bio Ltd. ("Lavie Bio"), a subsidiary of Evogene Ltd. ("Evogene") (Nasdaq: EVGN) (TASE: EVGN), and a leading ag-biologicals company focusing on improving food quality, sustainability, and agriculture productivity through the...
dateMar 29, 2023
Lavie Bio to Host a Round Table Discussion and is a Sponsor at World Agri-Tech Conference in San Francisco
REHOVOT, Israel, March 6, 2023 /PRNewswire/ -- Lavie Bio Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), and a leading ag-biological company focusing on improving food quality, sustainability, and agriculture productivity through the introduction of microbiome-based...

Web Summary

Q1: What is the address of Lavie Bio's headquarters?
A1: The address of Lavie Bio's headquarters is 13 Gad Feinstein Rehovot, 7638517 Israel.

Q2: What products does Lavie Bio develop and commercialize?
A2: Lavie Bio develops and commercializes ag-biologicals products, including bio-stimulants, bio-pesticides, and bio-insecticides. These products are based on microbiome-based technologies and aim to improve crop yields, reduce chemical residues, and promote sustainable agriculture practices.

Q3: What is the target market for Lavie Bio's products?
A3: The target market for Lavie Bio's products includes major agricultural producers in North America, Europe, and other regions. Specifically, the company has identified opportunities in wheat, soybean, corn, and fruit production.

Q4: What is the mission of Lavie Bio?
A4: The mission of Lavie Bio is to improve food quality, sustainability, and agriculture productivity through microbiome-based, AI-driven ag-biologicals products. The company aims to create a better future for consumers and farmers by promoting environmentally friendly agricultural practices.

Q5: Who are the key executives at Lavie Bio?
A5: The key executives at Lavie Bio include Amit Noam, CEO; Russ Putland, EVP Commercial & General Manager USA; and other senior management team members who drive the company's commercial and operational strategies.

Q6: What is the significance of Lavie Bio's technology platform?
A6: Lavie Bio's technology platform leverages advanced informatics technologies to analyze and design microbiome-based products. The platform uses a "big data" hub that integrates over 5 petabytes of interconnected data to model complex microbiome-host interactions, enabling the company to develop effective and sustainable agricultural solutions.

Q7: How does Lavie Bio validate its products?
A7: Lavie Bio validates its products using a biological screening & validation platform that translates in-silico predictions into results. The platform's "in-planta" component feeds back data into the in-silico component, creating a feedback loop that continuously improves prediction capabilities.

Q8: What is the relationship between Lavie Bio and Evogene Ltd?
A8: Lavie Bio is a subsidiary of Evogene Ltd., a pioneer in applied computational predictive biology. The two companies leverage each other's expertise and capabilities to develop novel products for life science markets, with Lavie Bio benefiting from Evogene's established experience in predictive biology.
Customs Data
As a purchaser
As a Supplier
Disable_icon
Get the Whole details
DisableData_png
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Disable_icon
Get the Whole details
DisableContact_png